Prot #PTI-428-06: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of PTI-428 in Subjects with Cystic Fibrosis

Project: Research project

StatusActive
Effective start/end date10/29/1810/29/21

Funding

  • MS Clinical Services, LLC (Prot #PTI-428-06)
  • Proteostasis Therapeutics, Inc. (Prot #PTI-428-06)